Ogretmen B - Search Results

1

Sphingolipid metabolism in cancer signalling and therapy.

Ogretmen B. Ogretmen B. Nat Rev Cancer. 2018 Jan;18(1):33-50. doi: 10.1038/nrc.2017.96. Epub 2017 Nov 17. Nat Rev Cancer. 2018. PMID: 29147025 Free PMC article. Review.

2

Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.

Ogretmen B, Hannun YA. Ogretmen B, et al. Drug Resist Updat. 2001 Dec;4(6):368-77. doi: 10.1054/drup.2001.0225. Drug Resist Updat. 2001. PMID: 12030784 Review.

3

Biologically active sphingolipids in cancer pathogenesis and treatment.

Ogretmen B, Hannun YA. Ogretmen B, et al. Nat Rev Cancer. 2004 Aug;4(8):604-16. doi: 10.1038/nrc1411. Nat Rev Cancer. 2004. PMID: 15286740 Review. No abstract available.

4

Sphingolipids in cancer: regulation of pathogenesis and therapy.

Ogretmen B. Ogretmen B. FEBS Lett. 2006 Oct 9;580(23):5467-76. doi: 10.1016/j.febslet.2006.08.052. Epub 2006 Sep 5. FEBS Lett. 2006. PMID: 16970943 Review.

5

Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.

Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B. Baran Y, et al. J Biol Chem. 2007 Apr 13;282(15):10922-34. doi: 10.1074/jbc.M610157200. Epub 2007 Feb 15. J Biol Chem. 2007. PMID: 17303574 Free article.

6

Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

Karahatay S, Thomas K, Koybasi S, Senkal CE, Elojeimy S, Liu X, Bielawski J, Day TA, Gillespie MB, Sinha D, Norris JS, Hannun YA, Ogretmen B. Karahatay S, et al. Cancer Lett. 2007 Oct 18;256(1):101-11. doi: 10.1016/j.canlet.2007.06.003. Epub 2007 Jul 9. Cancer Lett. 2007. PMID: 17619081 Free PMC article. Clinical Trial.

7

Roles of bioactive sphingolipids in cancer biology and therapeutics.

Saddoughi SA, Song P, Ogretmen B. Saddoughi SA, et al. Subcell Biochem. 2008;49:413-40. doi: 10.1007/978-1-4020-8831-5_16. Subcell Biochem. 2008. PMID: 18751921 Free PMC article. Review.

8

Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling.

Mukhopadhyay A, Saddoughi SA, Song P, Sultan I, Ponnusamy S, Senkal CE, Snook CF, Arnold HK, Sears RC, Hannun YA, Ogretmen B. Mukhopadhyay A, et al. FASEB J. 2009 Mar;23(3):751-63. doi: 10.1096/fj.08-120550. Epub 2008 Nov 21. FASEB J. 2009. PMID: 19028839 Free PMC article.

9

Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.

Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, Salas A, Ogretmen B. Ponnusamy S, et al. Future Oncol. 2010 Oct;6(10):1603-24. doi: 10.2217/fon.10.116. Future Oncol. 2010. PMID: 21062159 Free PMC article. Review.

10

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.

Salas A, Ponnusamy S, Senkal CE, Meyers-Needham M, Selvam SP, Saddoughi SA, Apohan E, Sentelle RD, Smith C, Gault CR, Obeid LM, El-Shewy HM, Oaks J, Santhanam R, Marcucci G, Baran Y, Mahajan S, Fernandes D, Stuart R, Perrotti D, Ogretmen B. Salas A, et al. Blood. 2011 Jun 2;117(22):5941-52. doi: 10.1182/blood-2010-08-300772. Epub 2011 Apr 28. Blood. 2011. PMID: 21527515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters